Experienced in Emphysema

Dr. Vijay P. Balasubramanian

Pulmonary Medicine | Intensive Care Medicine
7417 N Cedar Ave, Suite 101, 
Fresno, CA 
Offers Telehealth
Experienced in Emphysema
7417 N Cedar Ave, Suite 101, 
Fresno, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vijay Balasubramanian is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Fresno, California. Dr. Balasubramanian is rated as an Experienced provider by MediFind in the treatment of Emphysema. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Embolectomy.

His clinical research consists of co-authoring 68 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of Emphysema.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Internal Medicine in CA
Hospital Affiliations
Community Regional Medical Center
Saint Agnes Medical Center
Mercy Medical Center
Clovis Community Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

7417 N Cedar Ave, Suite 101, Fresno, CA 93720
Other Locations
FRESNO COMMUNITY HOSPITAL AND MEDICAL CENTER
2755 Herndon Ave, Clovis, CA 93611

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: Intravenous/Subcutaneous Treprostinil
Study Phase: Phase 4
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

68 Total Publications

REMI: Reconstructing Episodic Memory During Intrinsic Path Planning.
REMI: Reconstructing Episodic Memory During Intrinsic Path Planning.
Journal: ArXiv
Published: September 29, 2025
Similar Doctors
Advanced in Emphysema
Dr. Kuldeep S. Gill
Pulmonary Medicine | Intensive Care Medicine
Advanced in Emphysema
Dr. Kuldeep S. Gill
Pulmonary Medicine | Intensive Care Medicine
1660 E Herndon Ave, Suite 101, 
Fresno, CA 
 (0.4 miles away)
559-431-9753
Languages Spoken:
English, Hindi, Punjabi, Urdu
See accepted insurances

Kuldeep Gill is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Fresno, California. Dr. Gill is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Lung Metastases, Lung Nodules, Chronic Obstructive Pulmonary Disease (COPD), and Pleurisy.

Advanced in Emphysema
Dr. Chitra Kandaswamy
Pulmonary Medicine
Advanced in Emphysema
Dr. Chitra Kandaswamy
Pulmonary Medicine
1243 E Spruce Ave, Suite 104, 
Fresno, CA 
 (0.3 miles away)
559-326-7659
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chitra Kandaswamy is a Pulmonary Medicine provider in Fresno, California. Dr. Kandaswamy is rated as a Distinguished provider by MediFind in the treatment of Emphysema. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Tracheitis, and Asthma in Children.

Advanced in Emphysema
Dr. Pankaj D. Mehta
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine
Advanced in Emphysema
Dr. Pankaj D. Mehta
Pulmonary Medicine | Intensive Care Medicine | Sleep Medicine

University Faculty Associates Inc

2335 E Kashian Ln, Suite 260, 
Fresno, CA 
 (7.1 miles away)
559-256-5130
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Pankaj Mehta is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Fresno, California. Dr. Mehta is rated as a Distinguished provider by MediFind in the treatment of Emphysema. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Obstructive Sleep Apnea, Spinal Fusion, and Tissue Biopsy. Dr. Mehta is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Balasubramanian's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile